Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Apr 27;9(5):932.
doi: 10.3390/microorganisms9050932.

The Role of Lung Colonization in Connective Tissue Disease-Associated Interstitial Lung Disease

Affiliations

The Role of Lung Colonization in Connective Tissue Disease-Associated Interstitial Lung Disease

Alberto Ricci et al. Microorganisms. .

Abstract

Connective tissue diseases (CTDs) may frequently manifest with interstitial lung disease (ILD), which may severely impair quality and expectation of life. CTD-ILD generally has a chronic clinical course, with possible acute exacerbations. Although several lines of evidence indicate a relevant role of infections in the acute exacerbations of CTD-ILD, little information is available regarding the prevalence of infections in chronic CTD-ILD and their possible role in the clinical course. The aim of the present retrospective study was the identification of lung microbial colonization in broncho-alveolar lavage from patients affected by stable CTD-ILD with radiologically defined lung involvement. We demonstrated that 22.7% of patients with CTD-ILD display microbial colonization by Pseudomonas aeruginosa, Haemophilus influenzae, and non-tuberculous mycobacteria. Moreover, these patients display a major radiologic lung involvement, with higher impairment in lung function tests confirmed in a multivariate logistic regression analysis. Overall, the present study provides new information on lung colonization during CTD-ILD and its possible relationship with lung disease progression and severity.

Keywords: autoimmune disease; connective tissue diseases; high-resolution computed tomography; interstitial lung diseases; lung function tests; microbiota; pulmonary fibrosis.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Representative CT scan imaging demonstrating the fibrotic lung involvement in patients belonging to Group 1 (representing patients in absence of true pathogen in broncho-alveolar lavage) or Group 2 (representing patients in the presence of pathogens in broncho-alveolar lavage). Note the different fibrotic involvement. Note the ground glass and reticular opacities. Moreover, a relationship between traction bronchiectasis and bacterial colonization was not observed.
Figure 2
Figure 2
Pulmonary function test findings in patients with CTD-ILD. Group 1 (patients without bacterial colonization in broncho-alveolar lavage) or Group 2 (patients with bacterial colonization in broncho-alveolar lavage). * p < 0.05.

References

    1. Mathai S.C., Danoff S.K. Management of interstitial lung disease associated with connective tissue disease. BMJ. 2016;352:h6819. doi: 10.1136/bmj.h6819. - DOI - PMC - PubMed
    1. Alba M.A., Flores-Suárez L.F., Henderson A.G., Xiao H., Hu P., Nachman P.H., Falk R.J., Charles Jennette J. Interstitial lung disease in ANCA vasculitis. Autoimmun. Rev. 2017;16:722–729. doi: 10.1016/j.autrev.2017.05.008. - DOI - PMC - PubMed
    1. Picchianti Diamanti A., Markovic M., Argento G., Giovagnoli S., Ricci A., Laganà B., D’Amelio R. Therapeutic management of patients with rheumatoid arthritis and associated interstitial lung disease: Case report and literature review. Ther. Adv. Respir. Dis. 2017;11:64–72. doi: 10.1177/1753465816668780. - DOI - PMC - PubMed
    1. Travis W.D., Costabel U., Hansell D.M., King T.E., Lynch D.A., Nicholson A.G., Ryerson C.J., Ryu J.H., Selman M., Wells A.U., et al. An official American Thoracic Society/European Respiratory Society statement: Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am. J. Respir. Crit. Care Med. 2013;188:733–748. doi: 10.1164/rccm.201308-1483ST. - DOI - PMC - PubMed
    1. Cottin V., Hirani O., Hotchkin D.L., Nambiar A.M., Ogura T., Ogura M., Skowasch D., Park J.S., Poonyagariyagorn H.K., Wuyts W., et al. Presentation, diagnosis and clinical course of the spectrum of progressive fibrosing interstitial lung diseases. Eur. Respir. Rev. 2018;27:180076–180087. doi: 10.1183/16000617.0076-2018. - DOI - PMC - PubMed

LinkOut - more resources